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Diagnosis of Schistosoma mansoni without the Stool: Comparison of Three Diagnostic
Tests to Detect Schiostosoma mansoni Infection from Filtered Urine in Zambia
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Department of Molecular Microbiology and Immunology, School of Public Health, Johns Hopkins University,
Baltimore, Maryland; University Teaching Hospital, Department of Pathology and Microbiology, Lusaka, Zambia
Abstract. Diagnosis for intestinal Schistosoma mansoni lacks sensitivity and is arduous to conduct. The standard
diagnostic tests, Kato-Katz (KK) and circulating cathodic antigen (CCA) both lack sensitivity and with KK, require
obtaining, transporting, and examining fresh stool. We compared diagnostic efficacy of KK, CCA, and polymerase chain
reaction (PCR) to detect S. mansoni infection (species-specific DNA) from 89 filtered urine samples collected in Zambia.
The PCR was the strongest indicator of positive cases with sensitivity and specificity of 100% in comparison to CCA
(67% and 60%) and KK (50% and 100%). High positive and negative predictive values (100%) were also indicative of
robustness of PCR. The same pattern was observed when stratified for sex and age group-specific analysis. Diagnosis of
S. mansoni from filtered urine samples by PCR is an effective means to detect low intensity infection and would enhance
the effectiveness of surveillance and control programs of schistosomiasis.
INTRODUCTION
Schistosomiasis is one of the most widespread parasitic
infectious diseases that affect humankind. Globally an esti-
mated 200 million people are currently infected and an esti-
mated 800 million people are at risk in 74 countries with an
annual death of about 20,000 patients.1 The disease is widely
distributed in Africa, Western Asia, South America, and
South West Asia affecting a high proportion of populations,
especially children in developing countries causing major
socioeconomic and public health consequences. Its intestinal
form, Schistosoma mansoni is responsible for severe liver and
intestinal damage, physical growth retardation, and cognition
and memory problems.2 Mass drug administration (MDA) is
now being applied to control large-scale schistosomiasis in
Africa and elsewhere.3 The impact of MDA has been mea-
sured by change in disease prevalence and infection inten-
sity.4 Because the infection is easily spread, to implement a
better control and surveillance strategy before and after
MDA, it must rely upon proper diagnosis of asymptotic cases
especially for areas with low disease prevalence.
Currentlymost epidemiological assessment to detect infected
individuals with S. mansoni depends on direct examination of
Kato-Katz (KK) smears of fecal samples or else the use of com-
mercially available urine reagent strip tests for the detection of
circulating cathodic antigen (CCA) produced by viable worms.
TheKKparasitological technique,whichdepends ondiagnosing
parasite eggs in the human excreta, is the method of choice5 to
detect parasites in infected individuals. However, there are sev-
eral shortcomings of this method. In chronic and low intensity
infections these eggs appear sporadically and are difficult to
detect, therefore it lacks sensitivity.6–9Moreover, this technique
is limited caused by day-to-day fluctuation of egg output,10 espe-
cially in a post-treatment situation.11 As an alternative, a point-
of-care CCA urine test has been developed for the diagnosis of
S. mansoni12 and the CCA test has also been evaluated in low
endemic settings to assess its diagnostic performances.13
The CCA test depends on the detection of major antigen
regurgitated by adult worms.10 It has been easy to use in field
condition and needs minimal practical training; its use as a
field diagnosis, requiring improved sensitivity has been
extolled by Bergquist14 and recently demonstrated by Colley
and others.15 However, there are detractions. Positivity of
CCA is strongly correlated with S. mansoni infection intensi-
ties10 and sensitivity of CCA decreases in low infection set-
tings; light to moderate infections are frequently seen as
negative by reagent strip test.11,16 Moreover, CCA is also
prone to produce false positive results17 and inaccurately esti-
mates disease prevalence13 to light S. mansoni infections. As
MDA initiatives expand in many countries, the subsequent
decline in schistosome infection will require a more sensitive
diagnostic test for S. mansoni.
Recently, schistosome-specific DNA has been successfully
detected in Schistosoma haematobium from filtered urine18
and S. mansoni from feces, serum,19,20 and urine.21 The ampli-
fication reaction is capable of detecting as little as 1 fg of a
highly repetitive S. mansoniDNA sequence, showed no cross-
reactivity with other related helminthes,22 and always showed
high sensitivity and specificity. This diagnostic technique
depends on the polymerase chain reaction (PCR) and so far
has not been extensively used in human schistosomiasis
detection22; it is now important to demonstrate the usage of
PCR as a surveillance tool to monitor schistosomiasis preva-
lence in high and low endemic areas.
In this study, we used a simple tool to collect and transport
urine to laboratories18 and amplified highly repetitive DNA
fragments of S. mansoni that spans more than 10% of the
parasite genome.19 The diagnostic performance of this test was
also compared with traditional KK and CCA tests obtained
through fecal and urine samples of the subjects from endemic
areas of Zambia. This is the first study that compared all three
known and well-studied diagnostic tests for S. mansoni.
MATERIALS ANDMETHODS
Study population. The study was conducted among 100
participants living in an area known to be endemic for
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S. mansoni. Participants were adults 18–50 years of age and
resident in the study area for not less than a year. This age group
was chosen because of the perception of decreasing sensitivity
of egg detection and parasite load with advancing age.
Study design. The study was a component of the cross-
sectional study conducted to establish the prevalence of
S. mansoni-related morbidity and role of immunogenetics in
hepatosplenic schistosomiasis in four rural communities of
Kaoma district in Western province of Zambia. Participants
were randomly selected for the study after receiving con-
sent from participants. Single stool samples were processed
and examined for the presence of S. mansoni parasites.
Other than detection of S. mansoni CCA, urine samples
were also examined for possible S. haematobium infections.
The study was reviewed and approved by the University of
Zambia biomedical research ethics committee. Participant
samples were identified with unique study identification num-
bers and results were only known to the study clinician and
individual participants. Those found infected with S. mansoni
were treated by praziquantel by using a dose of 40 mg/kg
body weight.
KK and CCA test. Stool samples collected from each of
the recruited participants was processed and examined in the
field. Duplicate stool smears were prepared from single stool
samples using the KK technique as previously described.23,24
Briefly, smears were prepared using a 41.7 mg template,
stained with malachite green, and examined microscopically
for the presence or absence of S. mansoni eggs.
The presence of S. mansoni infections was also tested with
the CCA rapid test (Rapid Medical Diagnostics, Pretoria,
South Africa). The test was conducted according to the man-
ufacturer’s recommendation. Briefly, one drop of urine was
added into the cassette well and a drop of the reagent buffer
was added. The cassette was left undisturbed for 20 min
before the results were recorded. Two results are expected
with this test; either positive or negative. For a positive result,
both the control band and the test band appear red, whereas
in a negative test only the control line appears red. The
person performing this test was blinded from results of the
KK and vice versa.
Urine collection. Urine samples were collected between
10 am and 12 pm for optimum egg passage. All the partici-
pants provided urine samples in plastic bottles and ~50 mL
urine was passed through a 12.5 cm Whatman No. 3
(Whatman International, Maidstone, UK) filter paper, folded
in a cone marked with subject identification. This grade of
paper was selected because it is coarse, maintains a cone
shape when folded, and it retained both schistosome eggs
and DNA fragments from urine during filtration.18 The cone
was set in a plastic funnel to pass the urine. To avoid contam-
ination, plastic cups and funnels were used only once. After
filtration, the paper disc was opened and allowed to dry under
a fly-proof bed net before being packed with desiccant in
individual plastic sleeves until further use.
DNA extraction from urine. Inner quadrants of the folded
marked cones were used to extract the DNA. A consistent
number of 12 punches (~1 mm in diameter) of the paper
made by a regular paper puncher were subject for DNA
extraction. Each time the paper puncher was cleaned with
10% bleach solution and dried to avoid contamination. All
the paper discs from each sample were placed into a 1.5 mL
eppendorf tube containing 600 mL nuclease-free water. The
tubes were incubated at 95 °C for 10 min and then placed on
a rotator at room temperature overnight (16–18 hrs). The
water containing DNA was transferred to a Qiagen QIAmp
2 mL column tube. The DNA was precipitated and concen-
trated using the QIAmpDNA Blood Mini Kit (Qiagen, MD)
according to the manufacturer’s protocol. The DNA concen-
tration was measured using the NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies, Wilmington, DE)
and stored at −20 °C for future use.
PCR test. The PCR was administered on all 89 samples
of both sexes and different age groups. The PCR was carried
out by using forward (5¢ GATCTGAATCCGACCAACCG 3¢)
and reverse (5¢ ATATTAACGCCCACGCTCTC 3¢) primers20
to amplify the 110 bp region from a highly repeated 121 bp
fragment of S. mansoni described by Hamburger and others.19
The repetitive fragment constitutes at least 12% (600,000 copies/
cell) of the S. mansoni genome. All DNA samples had a con-
centration of 1–3 ng/mL. For amplification, 1 mL of DNA
served as PCR template. The total PCR reaction volume was
10 mL and consisted of 5 mL of PCR Master Mix, 2X (Promega,
Madison, WI), 0.5 mL (10 mM) of each of the amplification
primers, 0.5 mL of 25 mMMgCl2, and 2 mL of water to complete
the final volume. The amplification profile was an initial dena-
turation of 95°C for 5 min, followed by 40 cycles of 95°C for
30 sec, annealing temperature of 63 °C for 45 sec, and elon-
gation at 72 °C for 30 sec, followed by a final extension step
at 72 °C for 5 min. Electrophoresis of 4 mL amplified PCR
products was carried out in a 2% agarose gel stained with
ethidium bromide (10 mg/mL) with the help of 50 bp ladder
(New England BioLabs, Inc., Ipswich, MA) to estimate
band sizes.
Statistical analyses. Only samples with data from three
diagnostic tests were considered for analysis. Results were
recorded for all tests and converted to numerical values
(1 = positive and 0 = negative) for analysis. The positive
and negative assessment of each sample was based on the
following predictions.
If KK+, then sure presence of infection
If PCR+, then assume presence of infection
True Positive (TP): If PCR+, CCA+, and KK+
True Negative (TN): If PCR−, CCA−, and KK−
Positive: If PCR+ and KK−
False Negative (FN): If KK+ and PCR or CCA−
If CCA− and PCR or KK+
False Positive (FP): If CCA+ and PCR or KK−
The sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), positive and negative likeli-
hood ratio was calculated using MedCalc 12.4.0 (MedCalc
Software, Belgium). Disease prevalence was calculated based
Table 1
Comparative evaluation of the Kato-Katz (KK), circulating cathodic
antigen (CCA) and polymerase chain reaction (PCR) for diagnosis
of Schistosoma mansoni-infected people from Zambia
Diagnostic test True positive False positive True negative False negative Total
KK 45 0 10 34 89
CCA 53 4 6 26 89
PCR 79 0 10 0 89
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on number of positive cases by each diagnostic test. Agree-
ment statistics, which included Kappa value and Bowker’s
Symmetry, were determined (JMP v9, SAS Institute Inc.,
Cary, NC) to establish the agreement between two diagnostic
tests. Sex-specific and age group (7–19 yrs, 20–39 yrs, and
40–85 yrs)-specific evaluation (JMP v9, SAS Institute Inc.)
of positivity and negativity of each diagnostic test were also
done to establish the robustness of the PCR test.
RESULTS
The comparison of three diagnostic methods to detect
S. mansoni infection in the rural Zambian population is based
on performance of each test when a schistosome egg is pre-
sent in feces and most importantly when an egg is not present
or there is a low level of infection (asymptotic infection). The
PCR is the best indicator of disease prevalence among three
tests irrespective of age, sex, and infection level of a popula-
tion. Of the 89 samples that were tested, 79 were True positive
(TP) by PCR, whereas 45 and 53 tested positive by KK and
CCA. The PCR did not provide any False positive (FP) or
False negative results (FN; Table 1). The number FN was
highest with KK (34) and 26 by CCA. In comparison KK
positive is diagnostic, no FP, whereas CCA did show 4 FP.
Diagnostic parameters were calculated and showed 100%
sensitivity (95% CI: 95–100) and specificity (95% CI: 69–100)
for PCR (Table 2). The predictive values of sensitivity
for PCR were significantly higher than KK (57%, 95% CI:
45–68; specificity, 100%, 95% CI: 69–100) and CCA (67%,
95% CI: 56–77; 60%, 95% CI: 26–88). The PCR was also
more sensitive determining the disease prevalence (89%)
based on positive cases than KK (51%) and CCA (60%).
The PPV values for all three tests were close, ranging from
93% to 100%, but the NPV were variable, as it was 100% for
PCR and significantly lower for KK (23%) and CCA (19%).
In addition, the positive and negative likelihood ratio was also
reflective of PPV and NPV values for three diagnostic tests.
The agreement statistics also replicate our findings regard-
ing sensitivity and specificity of three tests. The PCR showed
a significantly low degree of agreement with KK (kappa: 0.23;
95% CI: 0.10–0.34; P < 0.05) and CCA (kappa: 0.14; 95% CI:
0.04–0.31; P < 0.05), whereas KK had a relatively high degree
of agreement with CCA (kappa: 0.50; 95% CI: 0.33–0.68;
P < 0.05; JMP v9, SAS Institute Inc.; Table 3). Kappa values
show the agreement between two tests compared at a time
(−1= negative association, 0= random, 1= complete agreement).
The symmetry for lack of agreement (Bowker Symmetry; JMP
v9, SAS Institute Inc.) between comparisons of two tests at a
time was all significant (P < 0.05). This test checks for symme-
try in two-way tables and the test decision is based on X2
approximation of the distribution of the test statistic.25 The
Bowker Symmetry is significantly different from random
(P < 0.05) for all comparisons, indicating that test positives
by three diagnostic tests are highly unlikely to be the same.
We extended our comparative analysis for three diagnostic
tests for both males and females. Out of 89 people, 51 were
female and 38 were male. For PCR the rate of positive
infection identification was 86% for females and 92% for
males (Table 4). In comparison it was 67% (female) and
61% (male) for CCA and even lower for KK (51% female,
50% male). Most importantly, more than half of the individ-
uals tested negative by KK and CCA for both males and
females came out positive by PCR, which is an indication of
high sensitivity.
For age group analysis, PCR was a stronger predictor
for infected individuals in comparison with KK and CCA.
We categorized all 89 individuals into three age groups
(see Materials andMethods) and assessed positive and negative
individuals by each test for each age group. The PCR detected
almost or more than 90% (82.1–93.7%) positive individuals
for all groups, whereas detection by KK and CCA was widely
distributed (KK: 32.1–75%; CCA: 46.4–73.3%; Table 5).
Interestingly, PCR remained consistent with detection of
infected individuals clearing all phases of life; on other hand,
Table 3
Agreement statistics were calculated for three diagnostic tests
Diagnostic test Degree of agreement - Kappa value 95% CI P value Bowker’s Symmetry test P value
KK vs. CCA 0.50 0.33–0.68 0.0001* 6.55 0.0105*
KK vs. PCR 0.23 0.10–0.34 0.0003* 34 0.0001*
CCA vs. PCR 0.14 0.04–0.31 0.0463* 16.13 0.0001*
* Significant.
KK = Kato-Katz; CCA = circulating cathodic antigen; PCR = polymerase chain reaction.
Table 2
Estimation of prevalence, sensitivity, specificity, predictive values, and likelihood ratios of three diagnostic tests for identifying Schistosoma
mansoni infection
Diagnostic test Disease prevalence* Sensitivity (95% CI) Specificity (95% CI)
Positive predictive
value (PPV)
Negative predictive
value (NPV)
Positive
likelihood
ratio†
Negative
likelihood
ratio‡
KK 51% 57%
(45–68%)
100%
(69–100%)
100% 23% 0 0.43
CCA 60% 67%
(56–77%)
60%
(26–88%)
93% 19% 1.68 0.55
PCR 89% 100%
(95–100%)
100%
(69–100%)
100% 100% 0 0
*Disease prevalence = number of positives by each test out of total number of samples that had been analyzed.
†Positive likelihood ratio = ratio between the probability of a positive test result given the presence of the disease and the probability of a positive test result given the absence of the disease.
‡Negative likelihood ratio = ratio between the probability of a negative test result given the presence of the disease and the probability of a negative test result given the absence of the disease.
CI = confidence interval; KK = Kato-Katz; CCA = circulating cathodic antigen; PCR = polymerase chain reaction.
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both KK and CCA had sensitivity as a person aged (KK:
32.1%; CCA: 46.4%).
DISCUSSION
Diagnostic tools appropriate for undertaking interventions
to control helminth infections are the key to their success.26
The accurate identification of infected populations at highest
risk and with low infection is necessary to implement an effec-
tive control program for an endemic area, which will improve
the assessment of drug efficacy and patient management.
Much will be lost in local elimination programs if a significant
number of low-level infections are not detected. The potential
for expansive transmission is real when even small numbers
of miracidia are released in water.27 This is the first study to
evaluate the performances of three diagnostic tests to detect
S. mansoni-infected individuals. For this study, we used the
novel urine filtration technique (which was also used for S.
haematobium) to isolate and amplify small fragments (121 bp)
of a highly repetitive DNA sequence of S. mansoni genome.
This enables detection of the parasite in urine because, first,
high representation of the DNA fragment obviates high
detection sensitivity, and second, such sequences evolve more
rapidly than the rest of the genome.19
With traditional parasitological techniques, the possibility
of false negatives and multiple sample requirements often
lead to suboptimal results.28 The KK examines 50 mg of a
stool specimen that is likely to be several 100 g in mass.
Hence, low-level infections are missed. In our study 34 of 89
samples (38%) were FN (Table 1), which is a clear indication
of loss of sensitivity of KK (57%, Table 2). An antigen
capture test, CCA test of S. mansoni, now in use as a point-
of-care rapid diagnostic, has only been validated against
the KK test with similar sensitivity problems.29 In fact, our
study also indicates loss of sensitivity (67%, Table 2) for
CCA, which is evident by the number of FN (26 of 89, 29%,
Table 1). It has also been reported by several authors that
even though it is easy to use, CCA shows reduced sensitivity
in detecting urine CCA in low endemic areas of S.
mansoni.11,13,16,29 Moreover, urine CCA produces similar dis-
ease prevalence of multiple KK thick smears10 and even mul-
tiple CCA testing does not improve the overall disease
prevalence in comparison with a single CCA test,15 this task
is made more difficult to rationalize when, as shown here,
neither CCA nor KK can detect all cases of parasitemia. The
high level of specificity of infection in the current study is also
related to the detection of S. mansoni-infected individuals,
where KK and PCR perform exceptionally well (100%) and
on the other hand CCA performs moderately (60%, Table 2).
This study has shown several significant advances in the
diagnosis of S. mansoni, and these are relevant for consider-
ation both in the laboratory and in the field, particularly
where programs are under way to reduce or eliminate trans-
mission. First, the demonstration that parasite-specific DNA
from urine can be detected in filter paper as shown by
Ibironke and others18 obviates the need for taking stool sam-
ples. This is a major change in logistics and makes handling of
specimens so much easier and safer. Second, there is a sub-
stantive increase in sensitivity. Our evidence shows that KK
missed 34 of 79 positive cases in a prevalence study in rural
Zambia, and CCA missed 26 of these cases (Table 1). In
endemic situations where treatment interventions are
planned, this omission is significant because even if all posi-
tive cases are cured, there is still a population of viable para-
sites to continue the parasite cycle, and the multiplicative
stage for the parasite is in the snails. Essentially, this and
other studies, e.g.,15 have cast doubt on the efficacy of the
KK test for use as a standard diagnostic unless there is a need
for some estimate of egg load, and that should be planned
with circumspection.
This study used PCR as the appropriate means to amplify
parasite DNA. However, use of thermocycler machines to
amplify DNA is not suited to field situations where electric
power is unstable or intermittent. There is a real need to
make these techniques that increase sensitivity available
under such conditions so that they can be used much closer
to the real life situation. To this end, the loop-mediated iso-
thermal amplification method has been developed for other
Table 5
Effectiveness of three diagnostic tests across different age groups for diagnosis of Schistosoma mansoni infection*
Diagnostic test
Age group A (7–19 yrs) Age group B (20–39 yrs) Age group C (40–85 yrs)
Positive Negative Positive Negative Positive Negative
KK 12 (75%) 4 24 (53.3%) 21 9 (32.1%) 19
CCA 11 (68.7%) 5 33 (73.3%) 12 13 (46.4%) 15
PCR 15 (93.7%) 1 41 (91.1%) 4 23 (82.1%) 5
*KK = Kato-Katz; CCA = circulating cathodic antigen; PCR = polymerase chain reaction.
Table 4
Positive and negative identification of Schistosoma mansoni infection by three diagnostic tests for both female and male*
Diagnostic test
Female
Total
Male
TotalPositive Negative Positive Negative
KK 26
51%
25
49%
51 19
50%
19
50%
38
CCA 34
67%
17
33%
51 23
61%
15
39%
38
PCR 44
86%
7
14%
51 35
92%
3
8%
38
*KK = Kato-Katz; CCA = circulating cathodic antigen; PCR = polymerase chain reaction.
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situations including detection of schistosome material in
infected snails.30 This should be a priority for an improved
detection method for human infection of schistosomes.
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